Interleukin-1 beta and interleukin-6 gene polymorphism associations with angiographically assessed coronary artery disease in Brazilians

Cytokine

Volumn 50, Issue 3, 2010, Pages 292-296

  Rios, Domingos L S ^a   Cerqueira, Caio C S ^b   Bonfim Silva, Ricardo ^b   Araújo, Luciana J ^c   Pereira, Jaqueline F ^c   Gadelha, Sandra R ^d   Barbosa, Ana A L ^b  

^a UNIVERSIDADE DO ESTADO DA BAHIA   (Brazil)

^b Univ Estadual Do Sudoeste Da B   (Brazil)

^c DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^d DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

Author keywords

African Brazilian; Coronary artery disease; Interleukin 1B; Interleukin 6; Polymorphism

Indexed keywords

CYTOSINE; GUANINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYMINE; TRIACYLGLYCEROL;

ADULT; AFRICA; ANGIOCARDIOGRAPHY; ARTICLE; BRAZIL; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

AFRICAN CONTINENTAL ANCESTRY GROUP; BRAZIL; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77952585414     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.02.012     Document Type: Article

References (51)

1. Paoletti R., Gotto A.M., Hajjar D.P. Inflammation in atherosclerosis and implications for therapy. Circulation 2004, 109:III20-III26.
2. Woods A., Brull D.J., Humphries S.E., Montgomery H.E. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 2000, 21:1574-1583.
3. Kristiansen O.P., Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes 2005, 54:S114-S124.
4. Andreotti F., Porto I., Crea F., Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 2002, 87:107-112.
5. Iacoviello L., Di Castelnuovo A., Gattone M., Pezzini A., Assanelli D., Lorenzet R., et al. IGIGI investigators. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 2005, 25:222-227.
6. Licastro F., Chiappelli M., Caldarera C.M., Tampieri C., Nanni S., Gallina M., et al. The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech Ageing Dev 2004, 125:575-579.
7. Jenny N.S., Tracy R.P., Ogg M.S., Luong le A., Kuller L.H., Arnold A.M., Sharrett A.R., Humphries S.E. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 2002, 22:2066-2071.
8. Georges J.L., Loukaci V., Poirier O., Evans A., Luc G., Arveiler D., et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Mol Med 2001, 79:300-305.
9. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., Miller G.J. The interleukin-6-174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001, 22:2243-2252.
10. Wang X.L., Oosterhof J., Duarte N. Peroxisome proliferator-activated receptor gamma C161 -->T polymorphism and coronary artery disease. Cardiovasc Res 1999, 44:588-594.
11. Rios D.L., D'Onofrio L.O., Souza J.K., Queiroz A.M., Raduy-Maron L., Silva-Neto N., et al. Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians. Atherosclerosis 2007, 193:135-141.
12. Rios D.L., D'Onofrio L.O., Cerqueira C.C., Bonfim-Silva R., Carvalho H.G., Santos-Filho A., et al. Paraoxonase 1 gene polymorphisms on angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians. Clin Chem Lab Med 2007, 45:874-878.
13. Azevedo E.S. Subgroup studies of black admixture within a mixed population of Bahia, Brazil. Ann Hum Genet 1980, 44:55-60.
14. Vohnout B., Di Castelnuovo A., Trotta R., D'Orazi A., Panniteri G., Montali A., et al. Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica 2003, 88:54-60.
15. Vickers M.A., Green F.R., Terry C., Mayosi B.M., Julier C., Lathrop M., et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002, 53:1029-1034.
16. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
17. Schneider S., Roessli D., Excoffier L. Arlequin ver. 2000: a software for population genetics data analysis. Genetics data analysis. Genetics and biometry laboratory 2000, University of Geneva, Switzerland.
18. Abramson J.H., Gahlinger P.M. Computer programs for epidemiologists: PEPI. Version 4.0 2001, Sagebrush Press, Salt Lake City.
19. Norioka K., Hara M., Harigai M., Kitani A., Hirose T., Hirose W., et al. Pretreatment of human vascular smooth muscle cells with interleukin-1 enhances interleukin-6 production and cell proliferation (action of IL-1 on vascular smooth muscle cells). Autoimmunity 1990, 7:41-50.
20. Offner F.A., Feichtinger H., Stadlmann S., Obrist P., Marth C., Klingler P., et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996, 148:1679-1688.
21. Cozzolino F., Torcia M., Aldinucci D., Ziche M., Almerigogna F., Bani D., et al. Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci USA 1990, 87:6487-6491.
22. Bochner B.S., Luscinskas F.W., Gimbrone M.A., Newman W., Sterbinsky S.A., Derse-Anthony C.P., et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin-1 activated endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991, 173:1553-1557.
23. Grames M., Breviario F., Pintucci G., Millet I., Dejana E., van Damme J., et al. Enhancement by interleukin-1 (IL-1) of plasminogen activator inhibitor (PA-I) activity in cultured human endothelial cells. Biochem Biophys Res Commun 1986, 139:720-727.
24. Grégoire F., De Broux N., Hauser N., Heremans H., Van Damme J., Remacle C. Interferon-gamma and interleukin-1 beta inhibit adipoconversion in cultured rodent preadipocytes. J Cell Physiol 1992, 151:300-309.
25. Memon R.A., Feingold K.R., Moser A.H., Fuller J., Grunfeld C. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol 1998, 274:E210-E217.
26. Rus H.G., Vlaicu R., Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human atherosclerotic wall. Atherosclerosis 1996, 127:263-371.
27. Huber S.A., Sakkinen P., Conze D., Hardin N., Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1999, 19:2364-2367.
28. Mendonça M.I., Dos Reis R.P., Freitas A.I., Sousa A.C., Pereira A., Faria P., et al. Human paraoxonase gene polymorphisms and coronary artery disease risk. Rev Port Cardiol 2008, 27:1539-1555.
29. Collins A.R., Lyon C.J., Xia X., Liu J.Z., Tangirala R.K., Yin F., et al. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res 2009, 104:42-54.
30. Marculescu R., Mlekusch W., Exner M., Sabeti S., Michor S., Rumpold H., et al. Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty. Thromb Haemos 2003, 90:491-500.
31. Gadelha S.R., Alcantara L.C., Costa G.C., Rios D.L., Galvao-Castro B. Ethnic differences in the distribution of interleukin-6 polymorphisms among three Brazilian ethnic groups. Hum Biol 2005, 77:509-514.
32. Momiyama Y., Hirano R., Taniguchi H., Nakamura H., Ohsuzu F. Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol 2001, 38:712-717.
33. Zhang Y.M., Zhong L.J., He B.X., Li W.C., Nie J., Wang X., et al. The correlation between polymorphism at position -511C/T in the promoter region of interleukin 1B and the severity of coronary heart disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006, 23:86-88.
34. Francis S.E., Camp N.J., Dewberry R.M., Gunn J., Syrris P., Carter N.D., et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999, 99:861-866.
35. Burzotta F., Iacoviello L., Di Castelnuovo A., Glieca F., Luciani N., Zamparelli R., et al. Relation of the -174G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 2001, 88:1125-1128.
36. Flex A., Gaetani E., Pola R., Santoliquido A., Aloi F., Papaleo P., et al. The -174G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg 2002, 24:264-268.
37. Chapman C.M., Beilby J.P., Humphries S.E., Palmer L.J., Thompson P.L., Hung J. Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur Heart J 2003, 24:1494-1499.
38. Ikeda U., Ito T., Shimada K. Interleukin-6 and acute coronary syndrome. Clin Cardiol 2001, 24:701-704.
39. Bermudez E.A., Rifai N., Buring J.E., Manson J.E., Ridker P.M. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002, 89:1117-1119.
40. Rundek T., Elkind M.S., Pittman J., Boden-Albala B., Martin S., Humphries S.E., et al. Arotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 2002, 33:1420-1423.
41. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
42. Ishihara K., Hirano T. Molecular basis of the cell specificity of cytokine action. Biochim Biophys Acta 2002, 1592:281-296.
43. Humphries S.E., Luong L.A., Montgomery H.E., Day I.N., Mohamed-Ali V., Yudkin J.S. Gene-environment interaction in the determination of levels of plasma fibrinogen. Thromb Haemost 1999, 82:818-825.
44. Rauramaa R., Väisänen S.B., Luong L.A., Schmidt-Trücksäss A., Penttilä I.M., Bouchard C., et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 2000, 20:2657-2662.
45. Chiappelli M., Tampieri C., Tumini E., Porcellini E., Caldarera C.M., Nanni S., et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 2005, 32:349-353.
46. Nauck M., Winkelmann B.R., Hoffmann M.M., Böhm B.O., Wieland H., März W. The interleukin-6 G (-174) C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease and myocardial infarction. J Mol Med 2002, 80:507-513.
47. Lieb W., Pavlik R., Erdmann J., Mayer B., Holmer S.R., Fischer M., et al. No association of interleukin-6 gene polymorphism (-174G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol 2004, 97:205-212.
48. Sie M.P., Sayed-Tabatabaei F.A., Oei H.H., Uitterlinden A.G., Pols H.A., Hofman A., et al. Interleukin 6-174G/C promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 2006, 26:212-217.
49. Koukkou E., Watts G.F., Mazurkiewicz J., Lowy C. Ethnic differences in lipid and lipoprotein metabolism in pregnant women of African and Caucasian origin. J Clin Pathol 1994, 47:1105-1107.
50. Marchesi S., Lupattelli G., Sensini A., Lombardini R., Brozzetti M., Roscini A.R., et al. Racial difference in endothelial function: role of the infective burden. Atherosclerosis 2007, 191:227-234.
51. Momiyama Y., Ohmori R., Ohsuzu F. Association between IL-1ß gene polymorphism and myocardial infarction. Arterioscler Thromb Vasc Biol 2005, 25:e36.